Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Postmenopausal vaginal atrophy (PVA) refers to reduction in estrogen production after menopause and this condition is also called as vaginal atrophy. Less estrogen leads to thinning, drying, and decreased elasticity of vaginal tissues. Various other factors that lead to decrease in estrogen levels include perimenopause during breast feeding, surgical menopause, pelvic radiation therapy, and chemotherapy.
This report elaborates on the current development of the Postmenopausal Vaginal Atrophy Drugs industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
Actavis plc
Novo Nordisk A/S
Allergan plc
Shionogi & Company
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
Premarin
Vagifem
Estrace
Estring
Femring
Application:
Vaginal Gels
Creams
Tablets
Rings
Patches
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 Postmenopausal Vaginal Atrophy Drugs Industry Overview
-
1.1.1 Postmenopausal Vaginal Atrophy Drugs Market Scope and Market Segments
-
1.1.2 Postmenopausal Vaginal Atrophy Drugs Industry Characteristics
-
1.1.3 Global and China Postmenopausal Vaginal Atrophy Drugs Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China Postmenopausal Vaginal Atrophy Drugs Production Value and Growth Rate (2017-2028)
-
1.2 Global Postmenopausal Vaginal Atrophy Drugs Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 Premarin
-
1.2.2 Vagifem
-
1.2.3 Estrace
-
1.2.4 Estring
-
1.2.5 Femring
-
1.3 Global Postmenopausal Vaginal Atrophy Drugs Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 Vaginal Gels
-
1.3.2 Creams
-
1.3.3 Tablets
-
1.3.4 Rings
-
1.3.5 Patches
-
1.4 Market Analysis by Region
-
1.4.1 North America Postmenopausal Vaginal Atrophy Drugs Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe Postmenopausal Vaginal Atrophy Drugs Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC Postmenopausal Vaginal Atrophy Drugs Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa Postmenopausal Vaginal Atrophy Drugs Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global Postmenopausal Vaginal Atrophy Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global Postmenopausal Vaginal Atrophy Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China Postmenopausal Vaginal Atrophy Drugs Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China Postmenopausal Vaginal Atrophy Drugs Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global Postmenopausal Vaginal Atrophy Drugs Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 Postmenopausal Vaginal Atrophy Drugs Industry Porter's Five Forces Model Analysis
-
2.2.3 Postmenopausal Vaginal Atrophy Drugs Industry PEST Analysis
-
2.3 Postmenopausal Vaginal Atrophy Drugs Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 Postmenopausal Vaginal Atrophy Drugs Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on Postmenopausal Vaginal Atrophy Drugs Industry
Chapter 3 Global and China Postmenopausal Vaginal Atrophy Drugs Market, by Manufacturer
-
3.1 Global and China Postmenopausal Vaginal Atrophy Drugs Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China Postmenopausal Vaginal Atrophy Drugs Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China Postmenopausal Vaginal Atrophy Drugs Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China Postmenopausal Vaginal Atrophy Drugs Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China Postmenopausal Vaginal Atrophy Drugs Market Top 3 Players
Chapter 4 Global and China Postmenopausal Vaginal Atrophy Drugs Market, by Type (2017-2028)
-
4.1 Postmenopausal Vaginal Atrophy Drugs Market Trend, by Type
-
4.2 Global Postmenopausal Vaginal Atrophy Drugs Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global Postmenopausal Vaginal Atrophy Drugs Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global Postmenopausal Vaginal Atrophy Drugs Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global Postmenopausal Vaginal Atrophy Drugs Price Trend, by Type (2017-2028)
-
4.3 China Postmenopausal Vaginal Atrophy Drugs Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China Postmenopausal Vaginal Atrophy Drugs Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China Postmenopausal Vaginal Atrophy Drugs Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China Postmenopausal Vaginal Atrophy Drugs Price Trend, by Type (2017-2028)
Chapter 5 Global and China Postmenopausal Vaginal Atrophy Drugs Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global Postmenopausal Vaginal Atrophy Drugs Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global Postmenopausal Vaginal Atrophy Drugs Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global Postmenopausal Vaginal Atrophy Drugs Sales Value and Market Share, by Application (2017-2028)
-
5.3 China Postmenopausal Vaginal Atrophy Drugs Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China Postmenopausal Vaginal Atrophy Drugs Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China Postmenopausal Vaginal Atrophy Drugs Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global Postmenopausal Vaginal Atrophy Drugs Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China Postmenopausal Vaginal Atrophy Drugs Production, Import, Consumption and Export (2017-2022)
-
6.2 North America Postmenopausal Vaginal Atrophy Drugs Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe Postmenopausal Vaginal Atrophy Drugs Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC Postmenopausal Vaginal Atrophy Drugs Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa Postmenopausal Vaginal Atrophy Drugs Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America Postmenopausal Vaginal Atrophy Drugs Market Analysis
-
7.1 North America Postmenopausal Vaginal Atrophy Drugs Market, by Type
-
7.2 North America Postmenopausal Vaginal Atrophy Drugs Market, by Application
-
7.3 North America Postmenopausal Vaginal Atrophy Drugs Market Analysis and Forecast, by Country
-
7.3.1 United States Postmenopausal Vaginal Atrophy Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada Postmenopausal Vaginal Atrophy Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico Postmenopausal Vaginal Atrophy Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe Postmenopausal Vaginal Atrophy Drugs Market Analysis
-
8.1 Europe Postmenopausal Vaginal Atrophy Drugs Market, by Type
-
8.2 Europe Postmenopausal Vaginal Atrophy Drugs Market, by Application
-
8.3 Europe Postmenopausal Vaginal Atrophy Drugs Market Analysis and Forecast, by Country
-
8.3.1 Germany Postmenopausal Vaginal Atrophy Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK Postmenopausal Vaginal Atrophy Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France Postmenopausal Vaginal Atrophy Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy Postmenopausal Vaginal Atrophy Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries Postmenopausal Vaginal Atrophy Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain Postmenopausal Vaginal Atrophy Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium Postmenopausal Vaginal Atrophy Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland Postmenopausal Vaginal Atrophy Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia Postmenopausal Vaginal Atrophy Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey Postmenopausal Vaginal Atrophy Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC Postmenopausal Vaginal Atrophy Drugs Market Analysis
-
9.1 APAC Postmenopausal Vaginal Atrophy Drugs Market, by Type
-
9.2 APAC Postmenopausal Vaginal Atrophy Drugs Market, by Application
-
9.3 APAC Postmenopausal Vaginal Atrophy Drugs Market Analysis and Forecast, by Country
-
9.3.1 China Postmenopausal Vaginal Atrophy Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan Postmenopausal Vaginal Atrophy Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand Postmenopausal Vaginal Atrophy Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India Postmenopausal Vaginal Atrophy Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries Postmenopausal Vaginal Atrophy Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea Postmenopausal Vaginal Atrophy Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa Postmenopausal Vaginal Atrophy Drugs Market Analysis
-
10.1 Latin America, Middle East and Africa Postmenopausal Vaginal Atrophy Drugs Market, by Type
-
10.2 Latin America, Middle East and Africa Postmenopausal Vaginal Atrophy Drugs Market, by Application
-
10.3 Latin America, Middle East and Africa Postmenopausal Vaginal Atrophy Drugs Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries Postmenopausal Vaginal Atrophy Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil Postmenopausal Vaginal Atrophy Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria Postmenopausal Vaginal Atrophy Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa Postmenopausal Vaginal Atrophy Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina Postmenopausal Vaginal Atrophy Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China Postmenopausal Vaginal Atrophy Drugs Company Profiles
-
11.1 Actavis plc
-
11.1.1 Actavis plc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 Actavis plc Postmenopausal Vaginal Atrophy Drugs Product Profiles, Application and Specification
-
11.1.3 Actavis plc Postmenopausal Vaginal Atrophy Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.2 Novo Nordisk A/S
-
11.2.1 Novo Nordisk A/S Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.2.2 Novo Nordisk A/S Postmenopausal Vaginal Atrophy Drugs Product Profiles, Application and Specification
-
11.2.3 Novo Nordisk A/S Postmenopausal Vaginal Atrophy Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.3 Allergan plc
-
11.3.1 Allergan plc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.3.2 Allergan plc Postmenopausal Vaginal Atrophy Drugs Product Profiles, Application and Specification
-
11.3.3 Allergan plc Postmenopausal Vaginal Atrophy Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.4 Shionogi & Company
-
11.4.1 Shionogi & Company Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.4.2 Shionogi & Company Postmenopausal Vaginal Atrophy Drugs Product Profiles, Application and Specification
-
11.4.3 Shionogi & Company Postmenopausal Vaginal Atrophy Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 Postmenopausal Vaginal Atrophy Drugs Industry Investment Prospect and Risk Assessment
-
12.1 Postmenopausal Vaginal Atrophy Drugs Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 Postmenopausal Vaginal Atrophy Drugs Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global Postmenopausal Vaginal Atrophy Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure China Postmenopausal Vaginal Atrophy Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Global Postmenopausal Vaginal Atrophy Drugs Production Value and Growth Rate (2017-2028)
-
Figure China Postmenopausal Vaginal Atrophy Drugs Production Value and Growth Rate (2017-2028)
-
Figure Global Postmenopausal Vaginal Atrophy Drugs Market Size and Growth Rate of Premarin (2017-2028)
-
Figure Global Postmenopausal Vaginal Atrophy Drugs Market Size and Growth Rate of Vagifem (2017-2028)
-
Figure Global Postmenopausal Vaginal Atrophy Drugs Market Size and Growth Rate of Estrace (2017-2028)
-
Figure Global Postmenopausal Vaginal Atrophy Drugs Market Size and Growth Rate of Estring (2017-2028)
-
Figure Global Postmenopausal Vaginal Atrophy Drugs Market Size and Growth Rate of Femring (2017-2028)
-
Figure Global Postmenopausal Vaginal Atrophy Drugs Market Size and Growth Rate of Vaginal Gels (2017-2028)
-
Figure Global Postmenopausal Vaginal Atrophy Drugs Market Size and Growth Rate of Creams (2017-2028)
-
Figure Global Postmenopausal Vaginal Atrophy Drugs Market Size and Growth Rate of Tablets (2017-2028)
-
Figure Global Postmenopausal Vaginal Atrophy Drugs Market Size and Growth Rate of Rings (2017-2028)
-
Figure Global Postmenopausal Vaginal Atrophy Drugs Market Size and Growth Rate of Patches (2017-2028)
-
Figure North America Postmenopausal Vaginal Atrophy Drugs Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe Postmenopausal Vaginal Atrophy Drugs Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC Postmenopausal Vaginal Atrophy Drugs Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa Postmenopausal Vaginal Atrophy Drugs Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global Postmenopausal Vaginal Atrophy Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China Postmenopausal Vaginal Atrophy Drugs Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China Postmenopausal Vaginal Atrophy Drugs Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China Postmenopausal Vaginal Atrophy Drugs Sales Value, by Manufacturer (2021&2022)
-
Table Global and China Postmenopausal Vaginal Atrophy Drugs Market Share, by Manufacturer (2021&2022)
-
Figure Global and China Postmenopausal Vaginal Atrophy Drugs Market Share, by Manufacturer in 2021
-
Figure Global and China Postmenopausal Vaginal Atrophy Drugs Market Share, by Manufacturer in 2022
-
Table Global Postmenopausal Vaginal Atrophy Drugs Sales Volume, by Type (2017-2028)
-
Table Global Postmenopausal Vaginal Atrophy Drugs Sales Volume Share, by Type (2017-2028)
-
Figure Global Postmenopausal Vaginal Atrophy Drugs Sales Volume Share, by Type (2017-2028)
-
Table Global Postmenopausal Vaginal Atrophy Drugs Sales Value, by Type (2017-2028)
-
Table Global Postmenopausal Vaginal Atrophy Drugs Sales Value Share, by Type (2017-2028)
-
Figure Global Postmenopausal Vaginal Atrophy Drugs Price Trend, by Type (2017-2028)
-
Table China Postmenopausal Vaginal Atrophy Drugs Sales Volume, by Type (2017-2028)
-
Table China Postmenopausal Vaginal Atrophy Drugs Sales Volume Share, by Type (2017-2028)
-
Figure China Postmenopausal Vaginal Atrophy Drugs Sales Volume Share, by Type (2017-2028)
-
Table China Postmenopausal Vaginal Atrophy Drugs Sales Value, by Type (2017-2028)
-
Table China Postmenopausal Vaginal Atrophy Drugs Sales Value Share, by Type (2017-2028)
-
Figure China Postmenopausal Vaginal Atrophy Drugs Price Trend, by Type (2017-2028)
-
Table Global Postmenopausal Vaginal Atrophy Drugs Sales Volume, by Application (2017-2028)
-
Table Global Postmenopausal Vaginal Atrophy Drugs Sales Volume Share, by Application (2017-2028)
-
Figure Global Postmenopausal Vaginal Atrophy Drugs Sales Volume Share, by Application (2017-2028)
-
Table Global Postmenopausal Vaginal Atrophy Drugs Sales Value, by Application (2017-2028)
-
Table Global Postmenopausal Vaginal Atrophy Drugs Sales Value Share, by Application (2017-2028)
-
Figure Global Postmenopausal Vaginal Atrophy Drugs Sales Value Share, by Application (2017-2028)
-
Table China Postmenopausal Vaginal Atrophy Drugs Sales Volume, by Application (2017-2028)
-
Table China Postmenopausal Vaginal Atrophy Drugs Sales Volume Share, by Application (2017-2028)
-
Figure China Postmenopausal Vaginal Atrophy Drugs Sales Volume Share, by Application (2017-2028)
-
Table China Postmenopausal Vaginal Atrophy Drugs Sales Value, by Application (2017-2028)
-
Table China Postmenopausal Vaginal Atrophy Drugs Sales Value Share, by Application (2017-2028)
-
Figure China Postmenopausal Vaginal Atrophy Drugs Sales Value Share, by Application (2017-2028)
-
Figure China Postmenopausal Vaginal Atrophy Drugs Production, Import, Consumption and Export (2017-2022)
-
Figure North America Postmenopausal Vaginal Atrophy Drugs Production, Import, Consumption and Export (2017-2022)
-
Figure Europe Postmenopausal Vaginal Atrophy Drugs Production, Import, Consumption and Export (2017-2022)
-
Figure APAC Postmenopausal Vaginal Atrophy Drugs Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa Postmenopausal Vaginal Atrophy Drugs Production, Import, Consumption and Export (2017-2022)
-
Table North America Postmenopausal Vaginal Atrophy Drugs Sales Volume, by Type (2017-2028)
-
Table North America Postmenopausal Vaginal Atrophy Drugs Sales Volume Share, by Type (2017-2028)
-
Figure North America Postmenopausal Vaginal Atrophy Drugs Sales Volume Share, by Type (2017-2028)
-
Table North America Postmenopausal Vaginal Atrophy Drugs Sales Volume, by Application (2017-2028)
-
Table North America Postmenopausal Vaginal Atrophy Drugs Sales Volume Share, by Application (2017-2028)
-
Figure North America Postmenopausal Vaginal Atrophy Drugs Sales Volume Share, by Application (2017-2028)
-
Figure United States Postmenopausal Vaginal Atrophy Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure United States Postmenopausal Vaginal Atrophy Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Canada Postmenopausal Vaginal Atrophy Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Canada Postmenopausal Vaginal Atrophy Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Mexico Postmenopausal Vaginal Atrophy Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico Postmenopausal Vaginal Atrophy Drugs Sales Value and Growth Rate (2017-2028)
-
Table Europe Postmenopausal Vaginal Atrophy Drugs Sales Volume, by Type (2017-2028)
-
Table Europe Postmenopausal Vaginal Atrophy Drugs Sales Volume Share, by Type (2017-2028)
-
Figure Europe Postmenopausal Vaginal Atrophy Drugs Sales Volume Share, by Type (2017-2028)
-
Table Europe Postmenopausal Vaginal Atrophy Drugs Sales Volume, by Application (2017-2028)
-
Table Europe Postmenopausal Vaginal Atrophy Drugs Sales Volume Share, by Application (2017-2028)
-
Figure Europe Postmenopausal Vaginal Atrophy Drugs Sales Volume Share, by Application (2017-2028)
-
Figure Germany Postmenopausal Vaginal Atrophy Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Germany Postmenopausal Vaginal Atrophy Drugs Sales Value and Growth Rate (2017-2028)
-
Figure UK Postmenopausal Vaginal Atrophy Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure UK Postmenopausal Vaginal Atrophy Drugs Sales Value and Growth Rate (2017-2028)
-
Figure France Postmenopausal Vaginal Atrophy Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure France Postmenopausal Vaginal Atrophy Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Italy Postmenopausal Vaginal Atrophy Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Italy Postmenopausal Vaginal Atrophy Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries Postmenopausal Vaginal Atrophy Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries Postmenopausal Vaginal Atrophy Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Spain Postmenopausal Vaginal Atrophy Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Spain Postmenopausal Vaginal Atrophy Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Belgium Postmenopausal Vaginal Atrophy Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium Postmenopausal Vaginal Atrophy Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Poland Postmenopausal Vaginal Atrophy Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Poland Postmenopausal Vaginal Atrophy Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Russia Postmenopausal Vaginal Atrophy Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Russia Postmenopausal Vaginal Atrophy Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Turkey Postmenopausal Vaginal Atrophy Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey Postmenopausal Vaginal Atrophy Drugs Sales Value and Growth Rate (2017-2028)
-
Table APAC Postmenopausal Vaginal Atrophy Drugs Sales Volume, by Type (2017-2028)
-
Table APAC Postmenopausal Vaginal Atrophy Drugs Sales Volume Share, by Type (2017-2028)
-
Figure APAC Postmenopausal Vaginal Atrophy Drugs Sales Volume Share, by Type (2017-2028)
-
Table APAC Postmenopausal Vaginal Atrophy Drugs Sales Volume, by Application (2017-2028)
-
Table APAC Postmenopausal Vaginal Atrophy Drugs Sales Volume Share, by Application (2017-2028)
-
Figure APAC Postmenopausal Vaginal Atrophy Drugs Sales Volume Share, by Application (2017-2028)
-
Figure China Postmenopausal Vaginal Atrophy Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure China Postmenopausal Vaginal Atrophy Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Japan Postmenopausal Vaginal Atrophy Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Japan Postmenopausal Vaginal Atrophy Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Postmenopausal Vaginal Atrophy Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Postmenopausal Vaginal Atrophy Drugs Sales Value and Growth Rate (2017-2028)
-
Figure India Postmenopausal Vaginal Atrophy Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure India Postmenopausal Vaginal Atrophy Drugs Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries Postmenopausal Vaginal Atrophy Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries Postmenopausal Vaginal Atrophy Drugs Sales Value and Growth Rate (2017-2028)
-
Figure South Korea Postmenopausal Vaginal Atrophy Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea Postmenopausal Vaginal Atrophy Drugs Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa Postmenopausal Vaginal Atrophy Drugs Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Postmenopausal Vaginal Atrophy Drugs Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa Postmenopausal Vaginal Atrophy Drugs Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Postmenopausal Vaginal Atrophy Drugs Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa Postmenopausal Vaginal Atrophy Drugs Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa Postmenopausal Vaginal Atrophy Drugs Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries Postmenopausal Vaginal Atrophy Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries Postmenopausal Vaginal Atrophy Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Brazil Postmenopausal Vaginal Atrophy Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil Postmenopausal Vaginal Atrophy Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria Postmenopausal Vaginal Atrophy Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria Postmenopausal Vaginal Atrophy Drugs Sales Value and Growth Rate (2017-2028)
-
Figure South Africa Postmenopausal Vaginal Atrophy Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa Postmenopausal Vaginal Atrophy Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Argentina Postmenopausal Vaginal Atrophy Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina Postmenopausal Vaginal Atrophy Drugs Sales Value and Growth Rate (2017-2028)
-
Table Actavis plc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Actavis plc Product Profiles, Application and Specification
-
Table Actavis plc Postmenopausal Vaginal Atrophy Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Novo Nordisk A/S Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Novo Nordisk A/S Product Profiles, Application and Specification
-
Table Novo Nordisk A/S Postmenopausal Vaginal Atrophy Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Allergan plc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Allergan plc Product Profiles, Application and Specification
-
Table Allergan plc Postmenopausal Vaginal Atrophy Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Shionogi & Company Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Shionogi & Company Product Profiles, Application and Specification
-
Table Shionogi & Company Postmenopausal Vaginal Atrophy Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
